There was a big press release this month that announced new Canadian approval for adjuvant treatment in stage 3 patients – Tafinlar (dabrafenib) plus Mekinist (trametinib) for melanoma patients (with the BRAF V600 mutation).
As I approach my 5 year NED mark, being in my early 30’s I start to think more about pregnancy.
The AJCC just released their new 8th edition for staging…
So I carry on …
My heart broke into one million pieces this weekend.
#64 – thanks feedspot!
It’s been a little while since I last posted, so thought I would say hi!